Citigroup Upgrades Dr Reddy's Laboratories to Buy

Citigroup analyst Prashant Nair upgrades Dr Reddy's Laboratories (NYSE:RDY) from Sell to Buy.

Benzinga · 01/09/2020 16:42

Citigroup analyst Prashant Nair upgrades Dr Reddy's Laboratories (NYSE:RDY) from Sell to Buy.